Application of 1H NMR-based serum metabolomic studies for monitoring female patients with rheumatoid arthritis

Adam Zabek, Jerzy Swierkot, Anna Malak, Iga Zawadzka, Stanisław Deja, Katarzyna Bogunia-Kubik, Piotr Mlynarz

Research output: Contribution to journalArticle

27 Citations (Scopus)

Abstract

Rheumatoid arthritis is a chronic autoimmune-based inflammatory disease that leads to progressive joint degeneration, disability, and an increased risk of cardiovascular complications, which is the main cause of mortality in this population of patients. Although several biomarkers are routinely used in the management of rheumatoid arthritis, there is a high demand for novel biomarkers to further improve the early diagnosis of rheumatoid arthritis, stratification of patients, and the prediction of a better response to a specific therapy. In this study, the metabolomics approach was used to provide relevant biomarkers to improve diagnostic accuracy, define prognosis and predict and monitor treatment efficacy. The results indicated that twelve metabolites were important for the discrimination of healthy control and rheumatoid arthritis. Notably, valine, isoleucine, lactate, alanine, creatinine, GPC&&APC and histidine relative levels were lower in rheumatoid arthritis, whereas 3-hydroxyisobutyrate, acetate, NAC, acetoacetate and acetone relative levels were higher. Simultaneously, the analysis of the concentration of metabolites in rheumatoid arthritis and 3 months after induction treatment revealed that L1, 3-hydroxyisobutyrate, lysine, L5, acetoacetate, creatine, GPC. +. APC, histidine and phenylalanine were elevated in RA, whereas leucine, acetate, betaine and formate were lower. Additionally, metabolomics tools were employed to discriminate between patients with different IL-17A genotypes. Metabolomics may provide relevant biomarkers to improve diagnostic accuracy, define prognosis and predict and monitor treatment efficacy in rheumatoid arthritis.

Original languageEnglish (US)
Pages (from-to)544-550
Number of pages7
JournalJournal of Pharmaceutical and Biomedical Analysis
Volume117
DOIs
StatePublished - Jan 5 2016
Externally publishedYes

Fingerprint

Patient monitoring
Metabolomics
Physiologic Monitoring
Biomarkers
Rheumatoid Arthritis
Nuclear magnetic resonance
formic acid
Metabolites
Serum
Histidine
Acetates
Betaine
Interleukin-17
Creatine
Isoleucine
Valine
Acetone
Phenylalanine
Leucine
Alanine

Keywords

  • H NMR spectroscopy
  • Metabolomics
  • Rheumatoid arthritis

ASJC Scopus subject areas

  • Analytical Chemistry
  • Pharmaceutical Science
  • Drug Discovery
  • Spectroscopy
  • Clinical Biochemistry

Cite this

Application of 1H NMR-based serum metabolomic studies for monitoring female patients with rheumatoid arthritis. / Zabek, Adam; Swierkot, Jerzy; Malak, Anna; Zawadzka, Iga; Deja, Stanisław; Bogunia-Kubik, Katarzyna; Mlynarz, Piotr.

In: Journal of Pharmaceutical and Biomedical Analysis, Vol. 117, 05.01.2016, p. 544-550.

Research output: Contribution to journalArticle

Zabek, Adam ; Swierkot, Jerzy ; Malak, Anna ; Zawadzka, Iga ; Deja, Stanisław ; Bogunia-Kubik, Katarzyna ; Mlynarz, Piotr. / Application of 1H NMR-based serum metabolomic studies for monitoring female patients with rheumatoid arthritis. In: Journal of Pharmaceutical and Biomedical Analysis. 2016 ; Vol. 117. pp. 544-550.
@article{189c3d550739457fa41fe8c77b7d5b0b,
title = "Application of 1H NMR-based serum metabolomic studies for monitoring female patients with rheumatoid arthritis",
abstract = "Rheumatoid arthritis is a chronic autoimmune-based inflammatory disease that leads to progressive joint degeneration, disability, and an increased risk of cardiovascular complications, which is the main cause of mortality in this population of patients. Although several biomarkers are routinely used in the management of rheumatoid arthritis, there is a high demand for novel biomarkers to further improve the early diagnosis of rheumatoid arthritis, stratification of patients, and the prediction of a better response to a specific therapy. In this study, the metabolomics approach was used to provide relevant biomarkers to improve diagnostic accuracy, define prognosis and predict and monitor treatment efficacy. The results indicated that twelve metabolites were important for the discrimination of healthy control and rheumatoid arthritis. Notably, valine, isoleucine, lactate, alanine, creatinine, GPC&&APC and histidine relative levels were lower in rheumatoid arthritis, whereas 3-hydroxyisobutyrate, acetate, NAC, acetoacetate and acetone relative levels were higher. Simultaneously, the analysis of the concentration of metabolites in rheumatoid arthritis and 3 months after induction treatment revealed that L1, 3-hydroxyisobutyrate, lysine, L5, acetoacetate, creatine, GPC. +. APC, histidine and phenylalanine were elevated in RA, whereas leucine, acetate, betaine and formate were lower. Additionally, metabolomics tools were employed to discriminate between patients with different IL-17A genotypes. Metabolomics may provide relevant biomarkers to improve diagnostic accuracy, define prognosis and predict and monitor treatment efficacy in rheumatoid arthritis.",
keywords = "H NMR spectroscopy, Metabolomics, Rheumatoid arthritis",
author = "Adam Zabek and Jerzy Swierkot and Anna Malak and Iga Zawadzka and Stanisław Deja and Katarzyna Bogunia-Kubik and Piotr Mlynarz",
year = "2016",
month = "1",
day = "5",
doi = "10.1016/j.jpba.2015.10.007",
language = "English (US)",
volume = "117",
pages = "544--550",
journal = "Journal of Pharmaceutical and Biomedical Analysis",
issn = "0731-7085",
publisher = "Elsevier",

}

TY - JOUR

T1 - Application of 1H NMR-based serum metabolomic studies for monitoring female patients with rheumatoid arthritis

AU - Zabek, Adam

AU - Swierkot, Jerzy

AU - Malak, Anna

AU - Zawadzka, Iga

AU - Deja, Stanisław

AU - Bogunia-Kubik, Katarzyna

AU - Mlynarz, Piotr

PY - 2016/1/5

Y1 - 2016/1/5

N2 - Rheumatoid arthritis is a chronic autoimmune-based inflammatory disease that leads to progressive joint degeneration, disability, and an increased risk of cardiovascular complications, which is the main cause of mortality in this population of patients. Although several biomarkers are routinely used in the management of rheumatoid arthritis, there is a high demand for novel biomarkers to further improve the early diagnosis of rheumatoid arthritis, stratification of patients, and the prediction of a better response to a specific therapy. In this study, the metabolomics approach was used to provide relevant biomarkers to improve diagnostic accuracy, define prognosis and predict and monitor treatment efficacy. The results indicated that twelve metabolites were important for the discrimination of healthy control and rheumatoid arthritis. Notably, valine, isoleucine, lactate, alanine, creatinine, GPC&&APC and histidine relative levels were lower in rheumatoid arthritis, whereas 3-hydroxyisobutyrate, acetate, NAC, acetoacetate and acetone relative levels were higher. Simultaneously, the analysis of the concentration of metabolites in rheumatoid arthritis and 3 months after induction treatment revealed that L1, 3-hydroxyisobutyrate, lysine, L5, acetoacetate, creatine, GPC. +. APC, histidine and phenylalanine were elevated in RA, whereas leucine, acetate, betaine and formate were lower. Additionally, metabolomics tools were employed to discriminate between patients with different IL-17A genotypes. Metabolomics may provide relevant biomarkers to improve diagnostic accuracy, define prognosis and predict and monitor treatment efficacy in rheumatoid arthritis.

AB - Rheumatoid arthritis is a chronic autoimmune-based inflammatory disease that leads to progressive joint degeneration, disability, and an increased risk of cardiovascular complications, which is the main cause of mortality in this population of patients. Although several biomarkers are routinely used in the management of rheumatoid arthritis, there is a high demand for novel biomarkers to further improve the early diagnosis of rheumatoid arthritis, stratification of patients, and the prediction of a better response to a specific therapy. In this study, the metabolomics approach was used to provide relevant biomarkers to improve diagnostic accuracy, define prognosis and predict and monitor treatment efficacy. The results indicated that twelve metabolites were important for the discrimination of healthy control and rheumatoid arthritis. Notably, valine, isoleucine, lactate, alanine, creatinine, GPC&&APC and histidine relative levels were lower in rheumatoid arthritis, whereas 3-hydroxyisobutyrate, acetate, NAC, acetoacetate and acetone relative levels were higher. Simultaneously, the analysis of the concentration of metabolites in rheumatoid arthritis and 3 months after induction treatment revealed that L1, 3-hydroxyisobutyrate, lysine, L5, acetoacetate, creatine, GPC. +. APC, histidine and phenylalanine were elevated in RA, whereas leucine, acetate, betaine and formate were lower. Additionally, metabolomics tools were employed to discriminate between patients with different IL-17A genotypes. Metabolomics may provide relevant biomarkers to improve diagnostic accuracy, define prognosis and predict and monitor treatment efficacy in rheumatoid arthritis.

KW - H NMR spectroscopy

KW - Metabolomics

KW - Rheumatoid arthritis

UR - http://www.scopus.com/inward/record.url?scp=84944463857&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84944463857&partnerID=8YFLogxK

U2 - 10.1016/j.jpba.2015.10.007

DO - 10.1016/j.jpba.2015.10.007

M3 - Article

C2 - 26476882

AN - SCOPUS:84944463857

VL - 117

SP - 544

EP - 550

JO - Journal of Pharmaceutical and Biomedical Analysis

JF - Journal of Pharmaceutical and Biomedical Analysis

SN - 0731-7085

ER -